CYDYOTCPharmaceutical PreparationsFiscal year ends May 31
CytoDyn Inc.
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 14, 2026
$0.25+0.02 (+9.53%)
Close on Oct 19, 2026
- Market cap
- $345.56M
- P/E (TTM)
- –
- Dividend yield
- –
Community
Notes and questions about CytoDyn from other investors
No posts about CYDY yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.